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Recently there have been significant improvements inthe diagnosis and treatment of Ebstein anomaly. Cya-notic neonates with Ebstein anomaly are the subgroupat highest risk. Total mortality rate exceeded 80%
before 1986, and a mortality rate of 47% in 1986 to 1996 was
reported by Yetman and colleagues.1 No standardized treatment
protocol for these infants has been published in the literature. Early
surgical intervention within the first days of life showed good
outcome after a modified Starnes operation (closure of the tricus-
pid and pulmonary valve and an aortopulmonary shunt) in some
recent reports. We present the case of a neonate with severe
Ebstein anomaly and report on our treatment strategy.
Clinical Summary
Immediately after birth, the term neonate presented with severe
heart failure and desaturation. Mechanical ventilation and prosta-
glandin E (PGE) infusion were started. Echocardiography (Figure
1) showed Ebstein anomaly with severe tricuspid and pulmonary
valve regurgitation, a widely patent ductus arteriosus, and type II
atrial septal defect with a right-to-left shunt. A mortality of ap-
proximately 40% was estimated by means of the echocardio-
graphic score introduced by Celermajer and associates.2
After 6 weeks of intensive care treatment, pulmonary blood
flow continued to be scarce. PGE infusion could not be discontin-
ued. Cardiac catheterization showed functional pulmonary atresia,
and arterial oxygen saturation persisted at levels less than 65%.
A modified Starnes operation3 was performed, and the infant
slowly recovered. Echocardiography showed some residual blood
flow into the right ventricle, and left ventricular function had
normalized. At the age of 7 months, the infant underwent a
bidirectional Glenn procedure. Cardiomegaly declined, and trans-
cutaneous oxygen saturation was 85%. When the infant was 18
months old, a total cavopulmonary anastomosis was performed
with an 18-mm extracardial conduit. The child rapidly recovered
from both operations and is doing well now. The left ventricular
size is close to normal, right-sided structures are small, and arterial
oxygen saturation is more than 90%.
Retrospective Review
Since 1992, 17 symptomatic newborns with Ebstein anomaly have
been admitted to our unit. Two newborns had additional complex
heart disease and were excluded. Fifteen newborns with isolated
Ebstein anomaly were included into further evaluation. Five pa-
tients had cyanosis and heart failure, 8 patients had cyanosis, and
1 patient had heart failure. Arrhythmia as the presenting symptom
was observed in 1 patient, who only had mild cyanosis and
moderate heart failure.
The median observation time was 6.6 years (0.1-11.5 years). A
total of 13 of the 15 newborns needed PGE to support pulmonary
blood flow. A Starnes operation in the first 6 weeks of life was
performed in 3 patients during the first 6 weeks of life, 2 patients
died (1 patient underwent operation in another hospital), and 1
patient is alive. In the other 9 patients, PGE could be weaned and
an operation was postponed. Corrective surgery (tricuspid valvu-
loplasty creating a monocusp valve) was then performed in 6
patients aged 10 to 65 months (all alive) (Figure 2). Four patients
are awaiting reconstructive surgery.
Discussion
Ebstein anomaly is associated with a high morbidity and mortality
in symptomatic neonates.2 Looking at our data retrospectively, we
observed that most symptomatic newborns with Ebstein anomaly
benefit from declining pulmonary vascular resistance, which re-
sulted in augmented pulmonary blood flow. In our group of pa-
tients with Ebstein anomaly who needed PGE, most patients im-
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Figure 1. Chest x-ray film on day 28. Increased cardiothoracic
ratio of 0.8; superior vena cava shifted to the right and decreased
pulmonary vascular markings.
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proved within the first weeks, and an operation was postponed to
childhood. Then surgical reconstruction of the tricuspid valve is
possible and safe, and has a favorable long-term outcome.4
In contrast with our expectant approach, Knott-Craig and as-
sociates5 vote for early monocuspid reconstruction of the valve,
right ventriculorhaphy, subtotal closure of a type II atrial septal
defect, and aggressive reduction atrioplasty. The short-term out-
come is good, but the long-term outcome of this approach is not
known yet.
van Son and colleagues6 suggest early univentricular repair
within the first week of life. They treated 5 symptomatic newborns
without early mortality. This treatment algorithm in all symptom-
atic newborns with Ebstein anomaly would have led to a univen-
tricular heart condition in some patients, who could have been
candidates for an early or late biventricular repair after physiolog-
ical lowering of the pulmonary vascular resistance.
If the combination of severe tricuspid regurgitation and poor
right ventricular function is present and declining pulmonary re-
sistance does not lead to clinical improvement, operative interven-
tion is indicated. The growing number of case reports referring to
a successful modified Starnes operation shows that this operation
can be performed. However, we strongly encourage an expectant
approach in symptomatic neonates before a decision for surgical
management is made.
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Figure 2. Flow chart of 15 newborn infants with Ebstein anomaly. PGE, Prostaglandin E.
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